A review of public information. No hands-on testing, laboratory inspection or medical review is claimed.
Which products are actually named
Maximus’s official protocol guide names both sermorelin and tesamorelin, with low- and high-intensity sermorelin options. This is stronger evidence of an offering than a general blog article about growth hormone. It still does not establish the formulation, pharmacy, supplied quantity or availability for an individual patient. A clinician selects the protocol after evaluating the patient.
Sources: Maximus — growth hormone program, Maximus — choosing a protocol, EGRIFTA WR — prescribing information, FDA — compounding questions and answers
A program price is not every product’s price
The growth-hormone page displays $299.99 per month on a one-month plan, $274.99 on a two-month plan and $199.99 on a six-month plan. Those figures describe the program’s displayed choices. We could not establish that each price applies equally to both named medicines and every intensity, so the individual product files request a quote rather than assigning the lowest number to all variants.
Sources: Maximus — growth hormone program, Maximus — choosing a protocol, EGRIFTA WR — prescribing information, FDA — compounding questions and answers
What a useful quotation should contain
Ask for the selected medicine, intensity, exact supply period, total initial charge, required laboratory work and renewal terms. The reviewed page advertises supplies, shipping and monitoring, but these descriptions are not a personalized invoice. If a longer term is quoted as a monthly equivalent, establish whether it is paid in advance and what happens if the prescription changes.
Sources: Maximus — growth hormone program, Maximus — choosing a protocol, EGRIFTA WR — prescribing information, FDA — compounding questions and answers
Our assessment
The public protocol guide makes the menu understandable; product-specific billing remains the main missing detail. Tesamorelin’s approved brand has a narrow labeled indication, and a growth-hormone wellness program should not be confused with that approval. Our review documents the offer and unanswered cost questions; it does not verify the clinic’s clinical comparisons or predict treatment results.
Sources: Maximus — growth hormone program, Maximus — choosing a protocol, EGRIFTA WR — prescribing information, FDA — compounding questions and answers
Every offer in our file.
Sermorelin protocol
Provider-listed prescriptionThe official protocol guide names this medicine. Generic growth-hormone program prices do not establish its selected intensity, formulation or total bill.
Tesamorelin protocol
Provider-listed prescriptionThe official protocol guide names this medicine. Generic growth-hormone program prices do not establish its selected intensity, formulation or total bill.
Follow the evidence
Sources & price notes
Each source retains its own check date. Provider pages document advertised terms; they do not independently establish clinical outcomes.
- Maximus — growth hormone program ↗
Program-level prices vary by commitment. Do not assign the generic program price to every medication or intensity.
Checked October 9, 2026
- Maximus — choosing a protocol ↗
The official help article identifies sermorelin and tesamorelin. Product-specific quotations still require confirmation.
Checked October 9, 2026
- EGRIFTA WR — prescribing information ↗
Label defines the indication, limitations, contraindications and monitoring requirements. EGRIFTA WR is not indicated for weight-loss management.
Checked October 9, 2026
- FDA — compounding questions and answers ↗
Clinical and regulatory context. A compounded preparation is not FDA-approved.
Checked October 8, 2026